Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).
Victoria S BlinderAllision M DealBrenda GinosJennifer JansenAmylou C DueckGina L MazzaSydney HensonPhilip CarrLauren J RogakAnna WeissAnna RapperportMattias JonssonPatricia A SpearsDavid CellaFrancesca M GanyDeborah SchragEthan M BaschPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
In this report of a secondary outcome from a randomized clinical trial, FT screening as part of routine digital patient monitoring with PROs reduced the development, or worsening, of financial difficulties among patients undergoing systemic cancer therapy.